^
Association details:
| Biomarker: | SPI1 overexpression |
|---|---|
| Cancer: | Clear Cell Renal Cell Carcinoma |
| Drug Class: | Immunotherapy |
| Direction: | Resistant |
Evidence:
Source:
Title:
SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
Published date:
12/07/2022
Excerpt:
Non-responders to immunotherapy against ccRCC were more likely to express higher SPI1 levels than responders.
DOI:
10.1007/s12672-022-00592-0
